Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
3.690
+0.140 (3.94%)
Nov 4, 2024, 4:00 PM EST - Market closed
Sutro Biopharma Market Cap
Sutro Biopharma has a market cap or net worth of $302.45 million as of November 4, 2024. Its market cap has increased by 51.91% in one year.
Market Cap
302.45M
Enterprise Value
-108.50M
1-Year Change
51.91%
Ranking
Category
Stock Price
$3.69
Market Cap Chart
Since September 27, 2018, Sutro Biopharma's market cap has decreased from $336.80M to $302.45M, a decrease of -10.20%. That is a compound annual growth rate of -1.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 1, 2024 | 291.00M | 11.28% |
| Dec 29, 2023 | 261.50M | -43.69% |
| Dec 30, 2022 | 464.40M | -32.55% |
| Dec 31, 2021 | 688.50M | -17.85% |
| Dec 31, 2020 | 838.10M | 229.96% |
| Dec 31, 2019 | 254.00M | 23.24% |
| Dec 31, 2018 | 206.10M | -38.81% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AC Immune | 296.82M |
| Design Therapeutics | 294.43M |
| Delcath Systems | 294.01M |
| Sanara MedTech | 293.11M |
| Genfit | 291.78M |
| Personalis | 288.59M |
| Lyell Immunopharma | 286.72M |
| uniQure | 285.37M |